Domains featuring this topic
Explore the domains where this topic appears.
Alpha synuclein and Lrrk2 are key players in Parkinson's disease and related disorders, but their normal role has been confusing and controversial. Data from acute gene-editing based knockdown, followed by functional assays, will be presented.
We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.